Medicated
Consumer Health > Medicated Skin Care

Medicated Skin Care in Mexico

Mexico

Euromonitor International's Medicated Skin Care in Mexico market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 51  |  Publication date: Jun 2010
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Product coverage

Acne Treatments; Antiparasitics/Lice (Head and Body) Treatments; Antipruritics; Child-Specific Medicated Skin Care; Cold Sore Treatments; Haemorrhoid Treatments; Hair Loss Treatments; Medicated Shampoos; Nappy (Diaper) Rash Treatments; Topical Allergy Remedies/Antihistamines; Topical Antifungals; Topical Germicidals/Antiseptics; Vaginal Antifungals

Table of contents

CONSUMER HEALTH IN MEXICO : MARKET INSIGHT

EXECUTIVE SUMMARY

Dynamic growth in consumer health comes to a halt in 2009

H1N1 influenza epidemic transforms perception of self-medication

Emerging strength of generic products shapes the regulatory environment

Retailing becomes an important battle ground for pharmaceutical companies

Retail value to flatten over the forecast period

KEY TRENDS AND DEVELOPMENTS

Mexicans move to low-priced products

Generics and private label increase sales

New legislation to affect imports and the drug registry

Self-care education still lagging

Chronic diseases to drive growth

The creativity of OTC drug advertising in Mexico

Retailing becomes a major scenario for competitive wars

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009

Table 2 Life Expectancy at Birth 2004-2009

MARKET DATA

Table 3 Sales of Consumer Health by Sector: Value 2004-2009

Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009

Table 5 Consumer Health Company Shares by Value 2005-2009

Table 6 Consumer Health Brand Shares by Value 2006-2009

Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009

Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009

Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014

Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/Self-care and Preventative Medicine

Switches

Summary 1 OTC Healthcare Switches 2007-2009

DEFINITIONS

Sector and subsector definitions

Summary 2 Research Sources

LOCAL COMPANY PROFILES - MEXICO

BAYER DE MéXICO SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Bayer de México SA de CV: Key Facts

Summary 4 Bayer de México SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 5 Bayer de México SA de CV: Production Statistics 2009

COMPETITIVE POSITIONING

Summary 6 Bayer de México SA de CV: Competitive Position 2009

BOEHRINGER INGELHEIM PROMECO SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 7 Boehringer Ingelheim Promeco SA de CV: Key Facts

Summary 8 Boehringer Ingelheim Promeco SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 9 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2009

COMPETITIVE POSITIONING

Summary 10 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2009

FARMACIAS SIMILARES SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 11 Farmacias Similares SA de CV: Key Facts

Summary 12 Farmacias Similares SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 13 Farmacias Similares SA de CV: Competitive Position 2009

GENOMMA LAB INTERNACIONAL SAB DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 14 Genomma Lab Internacional SAB de CV: Key Facts

Summary 15 Genomma Lab Internacional SAB de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 16 Genomma Lab Internacional SAB de CV: Competitive Position 2009

GLAXOSMITHKLINE MéXICO SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 17 GlaxoSmithKline México SA de CV: Key Facts

Summary 18 GlaxoSmithKline México SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 19 GlaxoSmithKline México SA de CV: Production Statistics 2009

COMPETITIVE POSITIONING

Summary 20 GlaxoSmithKline México SA de CV: Competitive Position 2009

HERBALIFE INTERNACIONAL DE MéXICO SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 21 Herbalife Internacional de México SA de CV: Key Facts

Summary 22 Herbalife Internacional de México SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 23 Herbalife Internacional de México SA de CV: Competitive Position 2009

MERCK-MéXICO SA - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 24 Merck-México SA: Key Facts

Summary 25 Merck-México SA: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 26 Merck-México SA: Production Statistics 2009

COMPETITIVE POSITIONING

Summary 27 Merck-México SA: Competitive Position 2009

PFIZER SA DE CV - CONSUMER HEALTH - MEXICO

STRATEGIC DIRECTION

KEY FACTS

Summary 28 Pfizer SA de CV: Key Facts

Summary 29 Pfizer SA de CV: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 30 Pfizer SA de CV: Production Statistics 2009

COMPETITIVE POSITIONING

Summary 31 Pfizer SA de CV: Competitive Position 2009

Summary 32 Wyeth SA de CV: Competitive Position 2009

MEDICATED SKIN CARE IN MEXICO

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

Table 11 Sales of Medicated Skin Care by Subsector: Value 2004-2009

Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009

Table 13 Acne Treatments by Format: % Value Breakdown 2004-2009

Table 14 Medicated Skin Care Company Shares by Value 2005-2009

Table 15 Medicated Skin Care Brand Shares by Value 2006-2009

Table 16 Acne Treatments Brand Shares by Value 2006-2009

Table 17 Hair Loss Treatments Brand Shares by Value 2006-2009

Table 18 Forecast Sales of Medicated Skin Care by Subsector: Value 2009-2014

Table 19 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2009-2014

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2010